GE sells its Biopharma business for $21.4bn, but is its IPO cancelled or merely on hold?
Investors swerve traditional medical devices in favour of artificial intelligence-enabled diagnostics.
Big medtech is keeping its purse-strings closed – but private equity sees value in subsidiaries.
The industry has its work cut out to rebuild trust in the tech following doubts about one pioneer, IBM Watson.
Since becoming a pure-play health tech group Philips has been buying like crazy. Might Siemens Healthineers and GE Healthcare join in?
GE arrives to the spin-out party fashionably late.